TipRanks
Nurix Therapeutics (NRIX)
NASDAQ:NRIX
US Market
Want to see NRIX full AI Analyst Report?

Nurix Therapeutics (NRIX) Revenue by Segment

596 Followers

Revenue by Segment

Breaks down revenue by different business segments, highlighting which areas are driving growth and which may need strategic adjustments. This insight helps assess the company's diversification and focus.
Nurix’s steady base is Collaboration revenue (mid‑single to low‑double millions), while headline growth is driven by sporadic 'Other' milestone receipts (big jumps in mid‑2023 and mid‑2025). That pattern makes revenue highly lumpy and timing‑dependent; the drop to ~6.3M in Collaboration in Mar‑2026 underscores near‑term visibility risk. Treat 'Other' as nonrecurring income—monitor upcoming partnership milestones and disclosures to assess whether cash runway and valuation are supported by sustainable revenue or one‑time payments.
Date
Other
Collaboration
Jun 30, 2026
$0.00$9.04M
Mar 31, 2026
$0.00$6.25M
Dec 31, 2025
$0.00$13.58M
Sep 30, 2025
$0.00$7.89M
Jun 30, 2025
$30.00M$14.06M
Mar 31, 2025
$0.00$18.45M
Dec 31, 2024
$0.00$13.28M
Sep 30, 2024
$0.00$12.59M
Jun 30, 2024
$0.00$12.09M
Mar 31, 2024
$0.00$16.59M